Business of Biology --- Advances in life science research have enhanced our understanding of the human genome, human genetic variation, and the role that genes play in our everyday health, response to treatment and susceptibility to disease. This new frontier in genomic medicine ushers in both opportunity and peril for individuals, companies and societies. The objective in this interdisciplinary graduate course is to explore the intersections between science, technology, commerce and social policy as they come together to advance (and in some cases retard) progress toward more-personalized health care. The course is intended for graduate students in medicine, biomedical and health-related science, public health, law, engineering, and business interested in the future of health care. Due to variation in student backgrounds coming into the course, efforts are made to establish a shared vocabulary and knowledge base across the disciplines. Interdisciplinary student teams are assigned to a group research project which is presented at the end of the course. Class Notes: BIOMEDE 523 is cross-listed with HMP 630, PHRMACOL 620, BE 518, & ENGR 523. This class meets on four Thursday evenings from 5:30 pm - 8 pm in addition to Monday/Wednesday mornings. The Thursday meeting dates for 2017 are 9/7, 9/21, 9/28, and 10/12. Add Consent: Instructor Consent Required.